26
Participants
Start Date
January 29, 2019
Primary Completion Date
May 18, 2020
Study Completion Date
May 18, 2020
Clinical Trial Site, México
Clinical Trial Site, Mexicali
Clinical Trial Site, Baltimore
Clinical Trial Site, Columbus
Clinical Trial Site, Indianapolis
Clinical Trial Site, Detroit
Clinical Trial Site, Rochester
Clinical Trial Site, Chicago
Clinical Trial Site, Houston
Clinical Trial Site, Houston
Clinical Trial Site, San Antonio
Clinical Trial Site, Denver
Clinical Trial Site, Culiacán
Clinical Trial Site, St. George
Clinical Trial Site, Scottsdale
Clinical Trial Site, Tucson
Clinical Trial Site, Albuquerque
Clinical Trial Site, Portland
Clinical Trial Site, Boston
Clinical Trial Site, Al Mansurah
Clinical Trial Site, Alexandria
Clinical Trial Site, Asyut
Clinical Trial Site, Cairo
Clinical Trial Site, Chandigarh
Clinical Trial Site, Ludhiāna
Clinical Trial Site, Manipal
Clinical Trial Site, Nadiād
Clinical Trial Site, Tamil Nadu
Clinical Trial Site, Kuala Lumpur
Clinical Trial Site, Monterrey
Clinical Trial Site, London
Lead Sponsor
Alnylam Pharmaceuticals
INDUSTRY